Eligibility Module

Eligibility Module

The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.

Eligibility Module path is as follows:

Study -> Protocol Section -> Eligibility Module

Eligibility Module


Ignite Creation Date: 2025-12-24 @ 6:42 PM
Ignite Modification Date: 2025-12-24 @ 6:42 PM
NCT ID: NCT00933257
Eligibility Criteria: Inclusion criteria: * Phototype Skin II and III Integral skin test in the region * Willingness in following the study procedures and to be present in the clinic at the days and scheduled time for medical evaluations and for application of occlusion Exclusion criteria: * Lactation or pregnancy * Use of Antiinflammatory 30 days and/or immunossupression drugs until 3 months before volunteers selection * Disease which can cause immunosuppresion, such as diabetes, HIV * Concomitant use of photosensitivity drugs * History of sensitivity or photosensitivity with topic products * Cutaneous active disease which can modify the study results * History or activity of photodermatosis * Personal or family antecedents of cutaneous neoplasia photo induced * Presence of injury precursor of cutaneous neoplasia, such as melanociticos nevus and actinic keratosis * Intense exposure solar in the test region * Use of new drugs and/or cosmetics during the study * Previous participation in studies using the same product in test * Relevant history or confirmation of alcohol or other drugs abuse * Intolerance detected or suspected for some component of the sample tested * Medecin or sponsor employees or their close family. The above information is not intended to contain all considerations relevant to a patient's potential participation in a clinical trial.
Healthy Volunteers: True
Sex: ALL
Minimum Age: 18 Years
Maximum Age: 60 Years
Study: NCT00933257
Study Brief:
Protocol Section: NCT00933257